BioGerm Novel Coronavirus (2019-nCov) mutation B.1.1.7 detection kit has grand listed ——Help defend the Novel Coronavirus (2019-nCov)!

Publishdate:2021-02-01 Views:586

Introduction


In mid-December, the United Kingdom reported to WHO for the first time the emergence of a highly contagious mutant strain of the novel coronavirus B.1.1.7 mutant strain. On January 1st, 2021, the Shanghai CDC isolated a B.1.1.7 subtype strain from imported cases in the UK; on January 3rd, the Guangdong Provincial CDC also isolated a B.1.1.7 subtype strain. At present, BioGerm Novel Coronavirus (2019-nCov) mutation detection kit has been officially launched.


Uncover the mystery of new strains


The strain first appeared in southeast England on September 20th, 2020, and is on an independent branch of evolution. The study found that the mutant strain had 14 amino acid mutations and 3 amino acid missing, which increased its transmission ability by 56% compared with other strains; Until now, the B.1.1.7 mutant strain has become the mainstream strain in the UK and has been detected in many countries in the world.



BioGerm’s Actions to the Novel Coronavirus (2019-nCov) B.1.1.7 mutant strains


BioGerm continued to pay close attention to the mutation trend of the new coronavirus, and immediately started the development of the B.1.1.7 mutant detection kit. At present, BioGerm Novel Coronavirus (2019-nCov) mutation detection kit has been officially launched.

This kit uses ARMS-PCR technology to design primers and probes for the N501Y mutation site and 69-70del mutation site of the S (Spike) gene of the Novel Coronavirus (2019-nCov) B.1.1.7 mutant strain to detect the presence of the above two mutation sites in the positive samples so that the wild Novel Coronavirus (2019-nCov) strains and B.1.1.7 mutant strains can be distinguished.

BioGerm Novel Coronavirus (2019-nCov) mutation B.1.1.7 detection kit can help identify the wild Novel Coronavirus (2019-nCov) strains and B.1.1.7 mutant strains quickly and efficiently without Sequencing and only need one regular PCR amplifier. It can also help monitor the epidemiological situation and origin of the B.1.1.7 mutant strains to defend the Novel Coronavirus (2019-nCov)!



Existing solutions will not miss the target gene and positive samples


In addition, BioGerm has completed the check of existing reagents, primers, probes and mutant strains. The result confirmed that BioGerm Novel Coronavirus (2019-nCov) mutation B.1.1.7 detection kit (Fluorescence PCR) will not miss the target gene and positive samples and can ensure the accuracy and sensitivity.